首页>
外国专利>
VEGF ANTAGONIST USE IN TREATMENT OF CHORIORETHINAL NEOVASCULAR DISORDERS AND PERMEABILITY DISORDERS IN PEDIATRIC PATIENTS
VEGF ANTAGONIST USE IN TREATMENT OF CHORIORETHINAL NEOVASCULAR DISORDERS AND PERMEABILITY DISORDERS IN PEDIATRIC PATIENTS
展开▼
机译:VEGF拮抗剂在儿童小儿胆囊性鼻窦神经疾病和通透性疾病中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the use of a VEGF antagonist in the treatment of chorioretinal neovascular or permeability disorders in children. In particular, the invention provides a VEGF antagonist for use in a method for treating a child having CNV or ME, wherein said method comprises administering to the eye of a child a VEGF antagonist that either does not enter or is rapidly cleared from the systemic circulation. The VEGF antagonist may be administered intravitreally, e.g. through injection, or topically, e.g. in form of eye drops. The invention further provides the use of a VEGF antagonist in the manufacture of a medicament for treating a child having a chorioretinal neovascular or permeability disorder.
展开▼